Equitech International Corporation Announces Purchase Order for Company's Proprietary Technology From Pfizer Pharmaceutical

Apr 30, 2001, 01:00 ET from Equitech International Corp.

    AIKEN, S.C., April 30 /PRNewswire/ --
 Equitech International Corp. (OTC Bulletin Board:   EQTL) received a purchase
 order for its new fiber optic based UV-Vis Chemical Process Analyzer from
 Pfizer Pharmaceutical.  Pfizer will use the online analyzer system to monitor
 product purity.  If the initial system performs as expected, Pfizer intends to
 install the system at other production facilities.
     Equitech International believes that its Chemical Process Analyzer is
 widely applicable to the pharmaceutical industry for online monitoring of
 production, quality, purity and strength of pharmaceuticals, as well as to
 verify the cleanliness of production equipment.  Equitech's high performance
 multiplexed and multi-channel capabilities offer a decided advantage over
 competitors in the field.
     Equitech is a Fiber Optic instrument company using UV-VIS technology with
 complete turnkey solutions to major problems in very large industrial and
 laboratory markets.  This is a large market and presently Equitech appears to
 be the only company capable of satisfying the requirements of the industry.
 
     For Further Information call: L. DeBeach @Joyce Research Group
 561-361-9277 or visit the website @ www.stockscommuter.com.
 
     The contents of this news release, as well as the expressions contained
 herein, including investment opinions, were prepared by JRG based upon
 information provided by the Company profiled, the Companies' filings with the
 Securities and Exchange Commission, as well as from independent market
 research and materials available to the general public. While JRG believes all
 sources to be reliable and accurate, JRG makes no representations as to the
 accuracy, completeness, or timeliness of the information provided. As such,
 all information is provided "as is" without warranty of any kind.  All
 statements and expressions contained on this report are provided for
 informational purposes only and should not be construed as investment advice,
 nor as an offer or solicitation to buy or sell the securities mentioned. The
 information provided contains forward-looking statements that involve risks
 and uncertainties.  A company's actual results could differ materially from
 those described in any forward-looking statements or announcements discussed
 in this report.  Information on potential factors that could affect the
 company's actual results is included in the Companies' filings with the
 Securities and Exchange Commission.  Neither JRG, nor its officers, directors,
 or employees/consultants accept liability whatsoever for any direct or
 consequential loss arising from any use of the material contained on this
 report. JRG is not a licensed broker, broker/dealer, market maker, investment
 banker, licensed/registered investment advisor, analyst or underwriter.
 Investing in securities is highly speculative and carries an extremely high
 degree of risk. Investors should verify all claims, conduct their own due
 diligence and consult with their brokers, financial planners, accountants,
 and/or business advisors before investing in any securities mentioned. JRG has
 been compensated by the company discussed on this report.  JRG, its
 affiliates, and/or its officers may buy, sell or have a position in the
 securities mentioned on this report and may profit in the event the shares of
 the company discussed on this report rise in value. Compensation from EQUITECH
 INTERNATIONAL CORP. is in the amount of 35,000 shares of stock to date.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X88178944
 
 

SOURCE Equitech International Corp.
    AIKEN, S.C., April 30 /PRNewswire/ --
 Equitech International Corp. (OTC Bulletin Board:   EQTL) received a purchase
 order for its new fiber optic based UV-Vis Chemical Process Analyzer from
 Pfizer Pharmaceutical.  Pfizer will use the online analyzer system to monitor
 product purity.  If the initial system performs as expected, Pfizer intends to
 install the system at other production facilities.
     Equitech International believes that its Chemical Process Analyzer is
 widely applicable to the pharmaceutical industry for online monitoring of
 production, quality, purity and strength of pharmaceuticals, as well as to
 verify the cleanliness of production equipment.  Equitech's high performance
 multiplexed and multi-channel capabilities offer a decided advantage over
 competitors in the field.
     Equitech is a Fiber Optic instrument company using UV-VIS technology with
 complete turnkey solutions to major problems in very large industrial and
 laboratory markets.  This is a large market and presently Equitech appears to
 be the only company capable of satisfying the requirements of the industry.
 
     For Further Information call: L. DeBeach @Joyce Research Group
 561-361-9277 or visit the website @ www.stockscommuter.com.
 
     The contents of this news release, as well as the expressions contained
 herein, including investment opinions, were prepared by JRG based upon
 information provided by the Company profiled, the Companies' filings with the
 Securities and Exchange Commission, as well as from independent market
 research and materials available to the general public. While JRG believes all
 sources to be reliable and accurate, JRG makes no representations as to the
 accuracy, completeness, or timeliness of the information provided. As such,
 all information is provided "as is" without warranty of any kind.  All
 statements and expressions contained on this report are provided for
 informational purposes only and should not be construed as investment advice,
 nor as an offer or solicitation to buy or sell the securities mentioned. The
 information provided contains forward-looking statements that involve risks
 and uncertainties.  A company's actual results could differ materially from
 those described in any forward-looking statements or announcements discussed
 in this report.  Information on potential factors that could affect the
 company's actual results is included in the Companies' filings with the
 Securities and Exchange Commission.  Neither JRG, nor its officers, directors,
 or employees/consultants accept liability whatsoever for any direct or
 consequential loss arising from any use of the material contained on this
 report. JRG is not a licensed broker, broker/dealer, market maker, investment
 banker, licensed/registered investment advisor, analyst or underwriter.
 Investing in securities is highly speculative and carries an extremely high
 degree of risk. Investors should verify all claims, conduct their own due
 diligence and consult with their brokers, financial planners, accountants,
 and/or business advisors before investing in any securities mentioned. JRG has
 been compensated by the company discussed on this report.  JRG, its
 affiliates, and/or its officers may buy, sell or have a position in the
 securities mentioned on this report and may profit in the event the shares of
 the company discussed on this report rise in value. Compensation from EQUITECH
 INTERNATIONAL CORP. is in the amount of 35,000 shares of stock to date.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X88178944
 
 SOURCE  Equitech International Corp.